An octopus-mimic PEGylated peptide as a specific integrin αvβ3 inhibitor for preventing tumor progression†
Abstract
We have developed a multivalent PEGylated RWrNR, named octopus-R, which exhibits good water solubility, biostability, biocompatibility and cancer targeting ability, endowing it with high anticancer potential. Octopus-R represents a promising theranostic agent and holds great potential for improving the management of malignant tumors.